-
1
-
-
0024539303
-
Seroepidemiology of human herpesvirus 6 infection in normal children and adults
-
Okuno T., Takahashi K., Balachandra K., Shiraki K., Yamanishi K., Takahashi M., Baba K. Seroepidemiology of human herpesvirus 6 infection in normal children and adults. J. Clin. Microbiol. 27:1989;651-653.
-
(1989)
J. Clin. Microbiol.
, vol.27
, pp. 651-653
-
-
Okuno, T.1
Takahashi, K.2
Balachandra, K.3
Shiraki, K.4
Yamanishi, K.5
Takahashi, M.6
Baba, K.7
-
3
-
-
0023891745
-
Identification of human herpesvirus-6 as a causal agent for exanthem subitum
-
Yamanishi K., Okuno T., Shiraki K., Takahashi M., Kondo T., Asano Y., Kurata T. Identification of human herpesvirus-6 as a causal agent for exanthem subitum. Lancet. 1:1988;1065-1967.
-
(1988)
Lancet
, vol.1
, pp. 1065-1967
-
-
Yamanishi, K.1
Okuno, T.2
Shiraki, K.3
Takahashi, M.4
Kondo, T.5
Asano, Y.6
Kurata, T.7
-
4
-
-
0035147492
-
Human herpesvirus-6 and -7 in transplantation
-
Dockrell D.H., Paya C.V. Human herpesvirus-6 and -7 in transplantation. Rev. Med. Virol. 11:2001;23-36.
-
(2001)
Rev. Med. Virol.
, vol.11
, pp. 23-36
-
-
Dockrell, D.H.1
Paya, C.V.2
-
5
-
-
0028801683
-
Human herpesvirus 6 in AIDS
-
Lusso P., Gallo R.C. Human herpesvirus 6 in AIDS. Immunol. Today. 16:1995;67-71.
-
(1995)
Immunol. Today
, vol.16
, pp. 67-71
-
-
Lusso, P.1
Gallo, R.C.2
-
6
-
-
0034121370
-
Human herpesvirus 6
-
Clark D.A. Human herpesvirus 6. Rev. Med. Virol. 10:2000;155-173.
-
(2000)
Rev. Med. Virol.
, vol.10
, pp. 155-173
-
-
Clark, D.A.1
-
7
-
-
0036321307
-
Human herpes virus 6 and multiple sclerosis
-
Moore F.G., Wolfson C. Human herpes virus 6 and multiple sclerosis. Acta Neurol. Scand. 106:2002;63-83.
-
(2002)
Acta Neurol. Scand.
, vol.106
, pp. 63-83
-
-
Moore, F.G.1
Wolfson, C.2
-
8
-
-
0035660708
-
Antiviral agents active against human herpesviruses HHV-6, HHV-7 and HHV-8
-
De Clercq E., Naesens L., De Bolle L., Schols D., Zhang Y., Neyts J. Antiviral agents active against human herpesviruses HHV-6, HHV-7 and HHV-8. Rev. Med. Virol. 11:2001;381-395.
-
(2001)
Rev. Med. Virol.
, vol.11
, pp. 381-395
-
-
De Clercq, E.1
Naesens, L.2
De Bolle, L.3
Schols, D.4
Zhang, Y.5
Neyts, J.6
-
9
-
-
0036765297
-
Role of the human herpesvirus 6 U69-encoded kinase in the phosphorylation of ganciclovir
-
De Bolle L., Michel D., Mertens T., Manichanh C., Agut H., De Clercq E., Naesens L. Role of the human herpesvirus 6 U69-encoded kinase in the phosphorylation of ganciclovir. Mol. Pharmacol. 62:2002;714-721.
-
(2002)
Mol. Pharmacol.
, vol.62
, pp. 714-721
-
-
De Bolle, L.1
Michel, D.2
Mertens, T.3
Manichanh, C.4
Agut, H.5
De Clercq, E.6
Naesens, L.7
-
10
-
-
0035341435
-
Human herpesviruses 6 and 7 in solid organ transplant recipients
-
Emery V.C. Human herpesviruses 6 and 7 in solid organ transplant recipients. Clin. Infect. Dis. 32:2001;1357-1360.
-
(2001)
Clin. Infect. Dis.
, vol.32
, pp. 1357-1360
-
-
Emery, V.C.1
-
11
-
-
0035215411
-
Cytomegalovirus therapy: Current constraints and future opportunities
-
Griffiths P.D. Cytomegalovirus therapy: current constraints and future opportunities. Curr. Opin. Infect. Dis. 14:2001;765-768.
-
(2001)
Curr. Opin. Infect. Dis.
, vol.14
, pp. 765-768
-
-
Griffiths, P.D.1
-
12
-
-
0036093153
-
Non-nucleoside inhibitors of herpesviruses
-
Wathen M.W. Non-nucleoside inhibitors of herpesviruses. Rev. Med. Virol. 12:2002;167-178.
-
(2002)
Rev. Med. Virol.
, vol.12
, pp. 167-178
-
-
Wathen, M.W.1
-
13
-
-
0034814181
-
Cellular proteins (cyclin dependent kinases) as potential targets for antiviral drugs
-
Schang L.M. Cellular proteins (cyclin dependent kinases) as potential targets for antiviral drugs. Antivir. Chem. Chemother. 12(Suppl. 1):2001;157-178.
-
(2001)
Antivir. Chem. Chemother.
, vol.12
, Issue.SUPPL. 1
, pp. 157-178
-
-
Schang, L.M.1
-
14
-
-
0033009115
-
Inhibitory effect of 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl) 1H - Imidazole on HCMV DNA replication and permissive infection
-
Johnson R.A., Huong S.M., Huang E.S. Inhibitory effect of 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)1H - imidazole on HCMV DNA replication and permissive infection. Antiviral Res. 41:1999;101-111.
-
(1999)
Antiviral Res.
, vol.41
, pp. 101-111
-
-
Johnson, R.A.1
Huong, S.M.2
Huang, E.S.3
-
15
-
-
0035112558
-
The role of MKK1/2 kinase activity in human cytomegalovirus infection
-
Johnson R.A., Ma X.L., Yurochko A.D., Huang E.S. The role of MKK1/2 kinase activity in human cytomegalovirus infection. J. Gen. Virol. 82:2001;493-497.
-
(2001)
J. Gen. Virol.
, vol.82
, pp. 493-497
-
-
Johnson, R.A.1
Ma, X.L.2
Yurochko, A.D.3
Huang, E.S.4
-
16
-
-
0030457879
-
Infection of human T lymphoid cells by human herpesvirus 6 is blocked by two unrelated protein tyrosine kinase inhibitors, biochanin a and herbimycin
-
Cirone M., Zompetta C., Tarasi D., Frati L., Faggioni A. Infection of human T lymphoid cells by human herpesvirus 6 is blocked by two unrelated protein tyrosine kinase inhibitors, biochanin A and herbimycin. AIDS Res. Hum. Retroviruses. 12:1996;1629-1634.
-
(1996)
AIDS Res. Hum. Retroviruses
, vol.12
, pp. 1629-1634
-
-
Cirone, M.1
Zompetta, C.2
Tarasi, D.3
Frati, L.4
Faggioni, A.5
-
17
-
-
0030843760
-
Effects of protein tyrosine kinase inhibitors on the replication of herpes simplex virus and the phosphorylation of viral proteins
-
Yura Y., Kusaka J., Tsujimoto H., Yoshioka Y., Yoshida H., Sato M. Effects of protein tyrosine kinase inhibitors on the replication of herpes simplex virus and the phosphorylation of viral proteins. Intervirology. 40:1997;7-14.
-
(1997)
Intervirology
, vol.40
, pp. 7-14
-
-
Yura, Y.1
Kusaka, J.2
Tsujimoto, H.3
Yoshioka, Y.4
Yoshida, H.5
Sato, M.6
-
18
-
-
18644374841
-
2-Chloro-3-pyridin-3-yl-5,6,7,8-tetrahydroindolizine-1-carboxamide (CMV423), a new lead compound for the treatment of human cytomegalovirus infections
-
Snoeck R., Andrei G., Bodaghi B., Lagneaux L., Daelemans D., De Clercq E., Neyts J., Schols D., Naesens L., Michelson S., Bron D., Otto M., Bousseau A., Nemecek C., Roy C. 2-Chloro-3-pyridin-3-yl-5,6,7,8-tetrahydroindolizine-1- carboxamide (CMV423), a new lead compound for the treatment of human cytomegalovirus infections. Antiviral Res. 55:2002;413-424.
-
(2002)
Antiviral Res.
, vol.55
, pp. 413-424
-
-
Snoeck, R.1
Andrei, G.2
Bodaghi, B.3
Lagneaux, L.4
Daelemans, D.5
De Clercq, E.6
Neyts, J.7
Schols, D.8
Naesens, L.9
Michelson, S.10
Bron, D.11
Otto, M.12
Bousseau, A.13
Nemecek, C.14
Roy, C.15
-
19
-
-
33745158157
-
A simple method of estimating fifty per cent endpoints
-
Reed L.J., Muench H. A simple method of estimating fifty per cent endpoints. Am. J. Hyg. 27:1938;493-497.
-
(1938)
Am. J. Hyg.
, vol.27
, pp. 493-497
-
-
Reed, L.J.1
Muench, H.2
-
20
-
-
0007495724
-
Antiviral activity of antiherpetic drugs in lymphoblast cells infected with HHV-6
-
Hommes OR, Wekerle H, Clanet M, editors. Amsterdam: Elsevier
-
Naesens L, De Bolle L, De Clercq E. Antiviral activity of antiherpetic drugs in lymphoblast cells infected with HHV-6. In: Hommes OR, Wekerle H, Clanet M, editors. Genes and viruses in multiple sclerosis. Amsterdam: Elsevier; 2001. p. 241-50.
-
(2001)
Genes and Viruses in Multiple Sclerosis
, pp. 241-250
-
-
Naesens, L.1
De Bolle, L.2
De Clercq, E.3
-
21
-
-
0031957563
-
Temporal mapping of transcripts in herpesvirus 6 variants
-
Mirandola P., Menegazzi P., Merighi S., Ravaioli T., Cassai E., Di Luca D. Temporal mapping of transcripts in herpesvirus 6 variants. J. Virol. 72:1998;3837-3844.
-
(1998)
J. Virol.
, vol.72
, pp. 3837-3844
-
-
Mirandola, P.1
Menegazzi, P.2
Merighi, S.3
Ravaioli, T.4
Cassai, E.5
Di Luca, D.6
-
22
-
-
0034212283
-
Susceptibility of human herpesvirus 6 to antiviral compounds by flow cytometry analysis
-
Manichanh C., Grenot P., Gautheret-Dejean A., Debre P., Huraux J.M., Agut H. Susceptibility of human herpesvirus 6 to antiviral compounds by flow cytometry analysis. Cytometry. 40:2000;135-140.
-
(2000)
Cytometry
, vol.40
, pp. 135-140
-
-
Manichanh, C.1
Grenot, P.2
Gautheret-Dejean, A.3
Debre, P.4
Huraux, J.M.5
Agut, H.6
-
23
-
-
0032802986
-
Selective activity of various antiviral compounds against HHV-7 infection
-
Zhang Y., Schols D., De Clercq E. Selective activity of various antiviral compounds against HHV-7 infection. Antiviral Res. 43:1999;23-35.
-
(1999)
Antiviral Res.
, vol.43
, pp. 23-35
-
-
Zhang, Y.1
Schols, D.2
De Clercq, E.3
-
24
-
-
0141708682
-
Characterization of the catalytic subunit of the human herpesvirus 6 (HHV-6) DNA polymerase expressed in an in vitro transcription/translation assay
-
De Bolle L., Balzarini J., De Clercq E., Naesens L. Characterization of the catalytic subunit of the human herpesvirus 6 (HHV-6) DNA polymerase expressed in an in vitro transcription/translation assay. Nucleosides Nucleotides Nucleic Acids. 22:2003;999-1001.
-
(2003)
Nucleosides Nucleotides Nucleic Acids
, vol.22
, pp. 999-1001
-
-
De Bolle, L.1
Balzarini, J.2
De Clercq, E.3
Naesens, L.4
-
25
-
-
0033052719
-
The U69 gene of human herpesvirus 6 encodes a protein kinase which can confer ganciclovir sensitivity to baculoviruses
-
Ansari A., Emery V.C. The U69 gene of human herpesvirus 6 encodes a protein kinase which can confer ganciclovir sensitivity to baculoviruses. J. Virol. 73:1999;3284-3291.
-
(1999)
J. Virol.
, vol.73
, pp. 3284-3291
-
-
Ansari, A.1
Emery, V.C.2
-
26
-
-
0033029240
-
9-(2-Phosphonylmethoxyethyl)adenine induces tumor cell differentiation or cell death by blocking cell cycle progression through the S phase
-
Hatse S., Schols D., De Clercq E., Balzarini J. 9-(2- Phosphonylmethoxyethyl)adenine induces tumor cell differentiation or cell death by blocking cell cycle progression through the S phase. Cell Growth Differ. 10:1999;435-446.
-
(1999)
Cell Growth Differ.
, vol.10
, pp. 435-446
-
-
Hatse, S.1
Schols, D.2
De Clercq, E.3
Balzarini, J.4
-
27
-
-
0033053592
-
Transcription of herpes simplex virus immediate-early and early genes is inhibited by roscovitine, an inhibitor specific for cellular cyclin-dependent kinases
-
Schang L.M., Rosenberg A., Schaffer P.A. Transcription of herpes simplex virus immediate-early and early genes is inhibited by roscovitine, an inhibitor specific for cellular cyclin-dependent kinases. J. Virol. 73:1999;2161-2172.
-
(1999)
J. Virol.
, vol.73
, pp. 2161-2172
-
-
Schang, L.M.1
Rosenberg, A.2
Schaffer, P.A.3
-
28
-
-
0025840561
-
Induction of host cell protein synthesis by human herpesvirus 6
-
Black J.B., Lopez C., Pellett P.E. Induction of host cell protein synthesis by human herpesvirus 6. Virus Res. 22:1992;13-23.
-
(1992)
Virus Res.
, vol.22
, pp. 13-23
-
-
Black, J.B.1
Lopez, C.2
Pellett, P.E.3
-
29
-
-
0035158948
-
Gene expression profile of herpesvirus-infected T cells obtained using immunomicroarrays: Induction of proinflammatory mechanisms
-
Mayne M., Cheadle C., Soldan S.S., Cermelli C., Yamano Y., Akhyani N., Nagel J.E., Taub D.D., Becker K.G., Jacobson S. Gene expression profile of herpesvirus-infected T cells obtained using immunomicroarrays: induction of proinflammatory mechanisms. J. Virol. 75:2001;11641-11650.
-
(2001)
J. Virol.
, vol.75
, pp. 11641-11650
-
-
Mayne, M.1
Cheadle, C.2
Soldan, S.S.3
Cermelli, C.4
Yamano, Y.5
Akhyani, N.6
Nagel, J.E.7
Taub, D.D.8
Becker, K.G.9
Jacobson, S.10
-
30
-
-
85047695528
-
Hsp-90-associated oncoproteins: Multiple targets of geldanamycin and its analogs
-
Blagosklonny M.V. Hsp-90-associated oncoproteins: multiple targets of geldanamycin and its analogs. Leukemia. 16:2002;455-462.
-
(2002)
Leukemia
, vol.16
, pp. 455-462
-
-
Blagosklonny, M.V.1
-
31
-
-
0031742097
-
The cyclin-dependent kinase inhibitors olomoucine and roscovitine arrest human fibroblasts in G1 phase by specific inhibition of CDK2 kinase activity
-
Alessi F., Quarta S., Savio M., Riva F., Rossi L., Stivala L.A., Scovassi A.I., Meijer L., Prosperi E. The cyclin-dependent kinase inhibitors olomoucine and roscovitine arrest human fibroblasts in G1 phase by specific inhibition of CDK2 kinase activity. Exp. Cell Res. 245:1998;8-18.
-
(1998)
Exp. Cell Res.
, vol.245
, pp. 8-18
-
-
Alessi, F.1
Quarta, S.2
Savio, M.3
Riva, F.4
Rossi, L.5
Stivala, L.A.6
Scovassi, A.I.7
Meijer, L.8
Prosperi, E.9
-
32
-
-
0034921680
-
Herpesvirus quiescence in neuronal cells IV: Virus activation induced by pituitary adenylate cyclase-activating polypeptide (PACAP) involves the protein kinase a pathway
-
Danaher R.J., Savells-Arb A.D., Black S.A.J., Jacob R.J., Miller C.S. Herpesvirus quiescence in neuronal cells IV: virus activation induced by pituitary adenylate cyclase-activating polypeptide (PACAP) involves the protein kinase A pathway. J. Neurovirol. 7:2001;163-168.
-
(2001)
J. Neurovirol.
, vol.7
, pp. 163-168
-
-
Danaher, R.J.1
Savells-Arb, A.D.2
Black, S.A.J.3
Jacob, R.J.4
Miller, C.S.5
-
33
-
-
0033013425
-
Indolocarbazoles: Potent selective inhibitors of human cytomegalovirus replication
-
Slater M.J., Cockerill S., Baxter R., Bonser R.W., Gohil K., Gowrie C., Robinson J.E., Littler E., Parry N., Randall R., Snowden W. Indolocarbazoles: potent selective inhibitors of human cytomegalovirus replication. Bioorg. Med. Chem. 7:1999;1067-1074.
-
(1999)
Bioorg. Med. Chem.
, vol.7
, pp. 1067-1074
-
-
Slater, M.J.1
Cockerill, S.2
Baxter, R.3
Bonser, R.W.4
Gohil, K.5
Gowrie, C.6
Robinson, J.E.7
Littler, E.8
Parry, N.9
Randall, R.10
Snowden, W.11
-
34
-
-
0033748564
-
Indolocarbazoles exhibit strong antiviral activity against human cytomegalovirus and are potent inhibitors of the pUL97 protein kinase
-
Zimmermann A., Wilts H., Lenhardt M., Hahn M., Mertens T. Indolocarbazoles exhibit strong antiviral activity against human cytomegalovirus and are potent inhibitors of the pUL97 protein kinase. Antiviral Res. 48:2000;49-60.
-
(2000)
Antiviral Res.
, vol.48
, pp. 49-60
-
-
Zimmermann, A.1
Wilts, H.2
Lenhardt, M.3
Hahn, M.4
Mertens, T.5
-
35
-
-
0035862995
-
Inhibition of herpes simplex virus type 1 by the experimental immunosuppressive agent leflunomide
-
Knight D.A., Hejmanowski A.Q., Dierksheide J.E., Williams J.W., Chong A.S., Waldman W.J. Inhibition of herpes simplex virus type 1 by the experimental immunosuppressive agent leflunomide. Transplantation. 71:2001;170-174.
-
(2001)
Transplantation
, vol.71
, pp. 170-174
-
-
Knight, D.A.1
Hejmanowski, A.Q.2
Dierksheide, J.E.3
Williams, J.W.4
Chong, A.S.5
Waldman, W.J.6
-
36
-
-
0343114297
-
Inhibition of cytomegalovirus in vitro and in vivo by the experimental immunosuppressive agent leflunomide
-
Waldman W.J., Knight D.A., Blinder L., Shen J., Lurain N.S., Miller D.M., Sedmak D.D., Williams J.W., Chong A.S. Inhibition of cytomegalovirus in vitro and in vivo by the experimental immunosuppressive agent leflunomide. Intervirology. 42:1999;412-418.
-
(1999)
Intervirology
, vol.42
, pp. 412-418
-
-
Waldman, W.J.1
Knight, D.A.2
Blinder, L.3
Shen, J.4
Lurain, N.S.5
Miller, D.M.6
Sedmak, D.D.7
Williams, J.W.8
Chong, A.S.9
-
37
-
-
0027347084
-
Inhibition of herpes simplex virus replication by genistein, an inhibitor of protein-tyrosine kinase
-
Yura Y., Yoshida H., Sato M. Inhibition of herpes simplex virus replication by genistein, an inhibitor of protein-tyrosine kinase. Arch. Virol. 132:1993;451-461.
-
(1993)
Arch. Virol.
, vol.132
, pp. 451-461
-
-
Yura, Y.1
Yoshida, H.2
Sato, M.3
-
38
-
-
0033975074
-
Roscovitine, a specific inhibitor of cellular cyclin-dependent kinases, inhibits herpes simplex virus DNA synthesis in the presence of viral early proteins
-
Schang L.M., Rosenberg A., Schaffer P.A. Roscovitine, a specific inhibitor of cellular cyclin-dependent kinases, inhibits herpes simplex virus DNA synthesis in the presence of viral early proteins. J. Virol. 74:2000;2107-2120.
-
(2000)
J. Virol.
, vol.74
, pp. 2107-2120
-
-
Schang, L.M.1
Rosenberg, A.2
Schaffer, P.A.3
-
39
-
-
0031009357
-
Inhibition of cellular Cdk2 activity blocks human cytomegalovirus replication
-
Bresnahan W.A., Boldogh I., Chi P., Thompson E.A., Albrecht T. Inhibition of cellular Cdk2 activity blocks human cytomegalovirus replication. Virology. 231:1997;239-247.
-
(1997)
Virology
, vol.231
, pp. 239-247
-
-
Bresnahan, W.A.1
Boldogh, I.2
Chi, P.3
Thompson, E.A.4
Albrecht, T.5
|